Patient Safety and Risk Management

PS-046

EVALUATION OF A SYSTEMATIC TOOL TO REDUCE INAPPROPRIATE PRESCRIBING (STRIP) IN ADULTS WITH INTELLECTUAL DISABILITY: A PILOT STUDY

PS-045

STUDY OF APPROPRIATENESS OF THE INDICATION FOR PARENTERAL NUTRITION FOR ADULT HOSPITALIZED PATIENTS

PS-043

MEDICINES ERRORS IN CRITICALLY ILL PATIENTS

PS-042

PARENTERAL NUTRITION (PN) IN PREMATURE INFANTS: RISK ANALYSIS AFTER REDESIGNING A PRODUCTION PROCESS

PS-041

POLYPHARMACY AND COMPLIANCE WITH START CRITERIA IN PATIENTS ADMITTED TO A REFERENCE HOSPITAL

PS-040

IMPACT OF DISPLACEMENT VALUES OF POWDERS FOR SOLUTION FOR INJECTION OR INFUSION ON DRUG DOSES ADMINISTERED TO CHILDREN

PS-039

DRUG SHORTAGES AND MEDICINES ERRORS

PS-037

DRUG RELATED PROBLEMS IN ONCOHAEMATOLOGIC OUTPATIENTS INCLUDED IN CLINICAL TRIALS

PS-036

THE PLACE OF MATERIOVIGILANCE AS TOOL OF TRACEABILITY IN THE QUALITY MANAGEMENT SYSTEM (QMS) IN HOSPITAL PHARMACY

PS-035

Are we aware of the risk of eye irritation caused by some eye drops, paradoxically, in the treatment of allergic conjunctivitis?

PS-034

HYPOPHOSPHATEMIA IN HIV PATIENTS TREATED WITH ANTIRETROVIRAL TREATMENT

PS-032

PHARMACEUTICAL VALIDATION AS SAFETY ASSURANCE FOR THE MANAGEMENT OF CYTOSTATICS

PS-031

EFFECTIVENESS AND SAFETY OF ANTIHYPERTENSIVE DRUGS IN ELDERLY PATIENTS

PS-030

RISK OF ANTICHOLINERGIC EFFECTS ESTIMATED IN POLYPATHOLOGICAL PATIENTS. THE IMPACT PROJECT

PS-029

IMPACT OF HAEMATOLOGICAL ADVERSE EVENTS OF TRIPLE THERAPY IN PATIENTS WITH HEPATITIS C

Pages